Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Livorno
Clinical trial register · Italy

Clinical Trials in Livorno, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6791 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:19 UTC
6791
Studies in scope
all four open statuses
4079
Recruiting now
open to new participants
1019
Lead sponsors
across recruiting studies
Top sites
Milan 2846 Bologna 1303 Roma 1272 Naples 983 Rome 968
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca10 Merck Sharp & Dohme LLC2 Regeneron Pharmaceuticals2 Pfizer2 Hoffmann-La Roche2
Site location
Milan2846 Bologna1303 Roma1272 Naples983 Rome968
All 489 locations
Target enrolment
to

Trials with a site in Livorno

34 of 6791 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Active, closed
Taiho Oncology, Inc.
Phase 3
360
Alessandria, Ancona, Bergamo, Bologna, Catania, Meldola, Livorno, Legnano
2025-12-22
Recruiting
Daiichi Sankyo
Phase 3
686
Bologna, Candiolo, Fano, Genova, Livorno, Milan, Misterbianco, Orbassano
2025-10-24
Not yet open
Federation Francophone de Cancerologie Digestive
Phase 2
300
Aviano, Catania, Florence, Livorno, Meldola, Milan, Monserrato, Padova
2025-08-31
Active, closed
Novo Nordisk A/S
Observational
245
Milan, Turin, Livorno, Lucca, Bergamo, Catanzaro, Naples, Perugia
2025-08-28
Recruiting
Relay Therapeutics, Inc.
Phase 3
540
Ancona, Brescia, Candiolo, Cona, Florence, Livorno, Meldola, Milan
2025-08-26
Recruiting
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
NCT06966700Breast Neoplasms, Triple Negative Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms
DrugsEpirubicin·Adriamycin·Xeloda·Sacituzumab tirumotecan
Merck Sharp & Dohme LLC
Phase 3
2,400
Monza, Livorno, Ancona, Bergamo, Genova, Milan, Pisa, Reggio Emilia
2025-06-30
Active, closed
Pfizer
Phase 1/2
74
Naples, Meldola, Aviano, Livorno, Bologna, Roma
2025-06-30
Recruiting
Immunovant Sciences GmbH
Phase 2
210
Rozzano, Acquaviva delle Fonti, Bergamo, Cuneo, Livorno, Milan, Naples, Pavia
2025-06-19
Recruiting
Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i.
NCT06382948Advanced Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer, ESR1 Gene Mutation
DrugsElacestrant·Everolimus
MedSIR
Phase 3
300
Bergamo, Cagliari, Florence, Genova, Livorno, Milan, Modena, Monza
2024-12-05
Recruiting
AstraZeneca
Phase 3
1,160
Florence, Legnano, Livorno, Monza, Peschiera del Garda, Rome
2024-11-27
Recruiting
AstraZeneca
Phase 3
1,160
Florence, Legnano, Livorno, Monza, Orbassano, Padova, Peschiera del Garda, Roma
2024-11-18
Recruiting
Gruppo Oncologico del Nord-Ovest
Phase 3
238
Brescia, Catania, Meldola, San Giovanni Rotondo, Florence, Tricase, Livorno, Lucca
2024-11-15
Active, closed
Regeneron Pharmaceuticals
Phase 2
195
Naples, Ferrara, Piacenza, Florence, Livorno, Bergamo, Milan, Pesaro
2024-07-16
Recruiting
Merck Sharp & Dohme LLC
Phase 3
348
Naples, Ravenna, Aviano, Rome, Milan, Livorno, Padova
2024-05-24
Recruiting
Hopital Foch
Phase 2
640
Milan, Livorno
2024-05-10
Recruiting
CarThera
Phase 3
560
Bologna, Livorno, Padua, Roma, Rozzano, Torino
2024-01-29
Active, closed
AstraZeneca
Phase 3
1,174
Bologna, Brescia, Florence, Genova, Livorno, Meldola, Messina, Milan
2022-11-28
Active, closed
AstraZeneca
Phase 3
594
Aviano, Livorno, Meldola, Milan, Monza, Naples, Padova, Parma
2022-09-15
Active, closed
Pfizer
Phase 2
108
Monserrato, Naples, Guastalla, San Giovanni Rotondo, Milan, Candiolo, Livorno, Pisa
2022-07-11
Active, closed
AstraZeneca
Phase 3
644
Borgo San Lorenzo, Catanzaro, Genova, Livorno, Milan, Modena, Naples, Province of Macerata
2022-05-16
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
654
Naples, Genoa, Monza (MB), Catania (CT), Torrette, Trento, Livorno, Prato
2022-03-07
Active, closed
Ascendis Pharma Oncology Division A/S
Phase 1/2
320
Cuneo, Florence, Grosseto, Lido di Camaiore, Livorno, Meldola, Milan, Modena
2022-01-11
Active, closed
AstraZeneca
Phase 3
927
Bologna, Candiolo, Livorno, Milan, Naples, Negrar, Padova, Roma
2021-10-25
Recruiting
Health-care Quality in Semi-intensive Care Units
NCT04676347Semi-intensive Care Unit, Evaluation, Quality
Mario Negri Institute for Pharmacological Research
Observational
39,000
Milan, Alessandria, Bassano del Grappa, Bologna, Catania, Cesena, Livorno, Lodi
2021-07-01
Active, closed
Hoffmann-La Roche
Phase 3
1,188
Avellino, Naples, Modena, Aviano, Rome, Brescia, Milan, Livorno
2021-05-04
Active, closed
AstraZeneca
Phase 3
1,157
Bergamo, Candiolo, Genova, Livorno, Milan, Naples, Padova, Rozzano
2021-04-26
Recruiting
Società Scientifica di Psicoterapia Strategica
Observational
450
Empoli, Livorno
2021-01-01
Active, closed
Hoffmann-La Roche
Phase 3
992
Meldola, Rome, Brescia, Milan, Monza, Misterbianco (CT), Candiolo, Livorno
2020-10-09
Active, closed
AstraZeneca
Phase 3
866
Aviano, Bergamo, Candiolo, Cona, Genova, Livorno, Messina, Milan
2020-07-24
Active, closed
AstraZeneca
Phase 3
818
Bergamo, Candiolo, Catanzaro, Livorno, Meldola, Milan, Modena, Naples
2020-04-16
Active, closed
Regeneron Pharmaceuticals
Phase 2
515
Milan, Bologna, Livorno, Novara, Perugia, Ravenna, Reggio Emilia, Varese
2019-11-13
Active, closed
Janssen Research & Development, LLC
Phase 1/2
125
Bergamo, Candiolo, Carpi, Catania, Ferrara, Lecco, Livorno, Milan
2018-04-05
Active, closed
Eli Lilly and Company
Phase 3
453
Catania, Genova, Livorno, Parma, Rome
2014-10-03
Active, closed
AstraZeneca
Phase 3
510
Bari, Genova, Livorno, Milan, Naples, Orbassano, Parma, Perugia
2013-09-25
Rows per page Showing 1–34 of 34
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 October 2026. https://priyalifescience.com/clinical-trials-italy/city/livorno

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,791 studies in total at the last sync on 11 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 34 of those studies with a site in Livorno.

How many clinical trials are recruiting in Livorno?

13 of the 34 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:19 UTC sync. A further 1 have not yet opened recruitment, 20 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Livorno), 34 studies
PhaseStudiesRecruitingShare
Phase 322964.7%
Phase 26217.6%
Observational328.8%
Phase 1/2308.8%

Most active sponsors

Lead sponsors with the most studies (Livorno)
Lead sponsorStudiesRecruiting
AstraZeneca102
Hoffmann-La Roche20
Merck Sharp & Dohme LLC22
Pfizer20
Regeneron Pharmaceuticals20
Ascendis Pharma Oncology Division A/S10
CarThera11
Daiichi Sankyo11
Eli Lilly and Company10
Federation Francophone de Cancerologie Digestive10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.